Literature DB >> 2967151

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view.

K G Alberti1, F A Gries.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is a very common disorder, but less attention is paid to it than to the more dramatic but less prevalent insulin-dependent diabetes. The majority of patients receive their care from primary health care physicians or doctors without particular training in diabetes. Care is highly variable and often inadequate. In the USA this problem has been tackled by promoting a national education programme involving extensive use of television together with written guidelines for management. These latter have been looked at with interest by many diabetologists in Europe, but it has been felt that the guidelines were not entirely suitable for European practice. As a result an initiative was taken to generate more suitable materials for European use. Diabetologists from 14 European countries, representing the European NIDDM Policy Group (EUR-NIDDM-PG) therefore met in Amsterdam in 1986 with the blessing of the Council of the European Region of the IDF. The aims were first to establish whether a concensus view on management of non-insulin-dependent diabetes could be achieved, and if this was possible then to produce written materials for use in the care of people with non-insulin-dependent diabetes aimed particularly at the primary health care sector and the general physician. A remarkable degree of concensus was reached considering the different backgrounds and specialties represented by the group. Discussions were lengthy but constructive and were pervaded by a determination to improve care for such patients in Europe. The first output from the group is the short concensus document which follows.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967151     DOI: 10.1111/j.1464-5491.1988.tb00984.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  48 in total

1.  Diagnostic confusion in diabetes with persistence of fetal haemoglobin.

Authors:  D A Robertson; F K Tunbridge; W G John; P D Home; K G Alberti
Journal:  BMJ       Date:  1992-09-12

2.  Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring.

Authors:  M Trovati; S Burzacca; E Mularoni; P Massucco; F Cavalot; L Mattiello; G Anfossi
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

3.  Targets for glycated haemoglobin. Glycated haemoglobin targets are attainable.

Authors:  P D Home
Journal:  BMJ       Date:  1995-07-15

4.  Does good practice organization improve the outcome of care for diabetic patients?

Authors:  N Dunn; R Pickering
Journal:  Br J Gen Pract       Date:  1998-05       Impact factor: 5.386

Review 5.  Insulin treatment in elderly patients with non-insulin-dependent diabetes mellitus. A double-edged sword?

Authors:  L Niskanen
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

Review 6.  The use of sulphonylureas in the elderly.

Authors:  M B Graal; B H Wolffenbuttel
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

7.  Impact of initial treatment on renal function in newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Vora; J Dolben; J D Williams; J R Peters; D R Owens
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

Review 8.  Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board.

Authors: 
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

Review 9.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 10.  The long and winding road to optimal HbA1c measurement.

Authors:  Randie R Little; Curt L Rohlfing
Journal:  Clin Chim Acta       Date:  2013-01-11       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.